CC BY-NC-ND 4.0 · World J Nucl Med 2021; 20(01): 93-95
DOI: 10.4103/wjnm.WJNM_118_20
Case Report

Xanthogranulomatous cholecystitis mimicking gallbladder cancer on 18F-fluorodeoxyglucose positron emission tomography/computed tomography scan

Nitin Gupta
Department of Nuclear Medicine and PET/CT Mahajan Imaging Centre, Sir Ganga Ram Hospital, New Delhi, India
,
Ritu Verma
Department of Nuclear Medicine and PET/CT Mahajan Imaging Centre, Sir Ganga Ram Hospital, New Delhi, India
,
Ethel Belho
Department of Nuclear Medicine and PET/CT Mahajan Imaging Centre, Sir Ganga Ram Hospital, New Delhi, India
,
Shashi Dhawan
1   Department of Pathology, Sir Ganga Ram Hospital, New Delhi, India
› Author Affiliations

Abstract

The abnormal thickening of the gallbladder (GB) wall can be caused by a malignant condition like gallbladder carcinoma or by benign lesions such as chronic cholecystitis or xanthogranulomatous cholecystitis (XGC). Mural thickening is a common finding between them as fluorodeoxyglucose (FDG) can be taken up by inflammatory cells also. Here, we present a patient with irregular thickening of the GB wall which was suspected to of GB carcinoma since FDG positron emission tomography/computed tomography scan showed increased tracer uptake in the lesion. However, after surgery the histopathological report was suggestive of XGC.

Financial support and sponsorship

Nil.




Publication History

Received: 13 August 2020

Accepted: 10 September 2020

Article published online:
30 March 2022

© 2021. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Zhuang PY, Zhu MJ, Wang JD, Zhou XP, Quan ZW, Shen J. Xanthogranulomatous cholecystitis: A clinicopathological study of its association with gallbladder carcinoma. J Dig Dis 2013;14:45-50.
  • 2 Christensen AH, Ishak KG. Benign tumors and pseudotumors of the gallbladder. Report of 180 cases. Arch Pathol 1970;90:423-32.
  • 3 McCoy JJ Jr., Vila R, Petrossian G, McCall RA, Reddy KS. Xanthogranulomatous cholecystitis. Report of two cases. J S C Med Assoc 1976;72:78-9.
  • 4 Zhao F, Lu PX, Yan SX, Wang GF, Yuan J, Zhang SZ, et al. CT and MR features of xanthogranulomatous cholecystitis: An analysis of consecutive 49 cases. Eur J Radiol 2013;82:1391-7.
  • 5 Bo X, Chen E, Wang J, Nan L, Xin Y, Wang C, et al. Diagnostic accuracy of imaging modalities in differentiating xanthogranulomatous cholecystitis from gallbladder cancer. Ann Transl Med 2019;7:627.
  • 6 Ewelukwa O, Ali O, Akram S. Xanthogranulomatous cholecystitis mimicking gallbladder cancer. BMJ Case Rep 2014;2014:bcr2013200530.
  • 7 Makino I, Yamaguchi T, Sato N, Yasui T, Kita I. Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma with a false-positive result on fluorodeoxyglucose PET. World J Gastroenterol 2009;15:3691-3.
  • 8 Han SH, Chen YL. Diagnosis and treatment of xanthogranulomatous cholecystitis: A report of 39 cases. Cell Biochem Biophys 2012;64:131-5.
  • 9 Goshima S, Chang S, Wang JH, Kanematsu M, Bae KT, Federle MP. Xanthogranulomatous cholecystitis: Diagnostic performance of CT to differentiate from gallbladder cancer. Eur J Radiol 2010;74:e79-83.
  • 10 Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 2004;8:90-7.
  • 11 Sawada S, Shimada Y, Sekine S, Shibuya K, Yoshioka I, Matsui K, et al. Expression of GLUT-1 and GLUT-3 in xanthogranulomatous cholecystitis induced a positive result on (18)F-FDG PET: Report of a case. Int Surg 2013;98:372-8.